Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 19

Results: 21

Chronological analysis of the gut microbiome for efficacy of atezolizumab‐based immunotherapy in non‐small cell lung cancer: Protocol for a multicenter prospective observational study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2829, doi. 10.1111/1759-7714.14640

By:

Shoji, Fumihiro;
Miura, Naoko;
Tagawa, Tetsuzo;
Tsukamoto, Shuichi;
Okamoto, Tatsuro;
Yamazaki, Koji;
Hamatake, Motoharu;
Takeo, Sadanori

Publication type:

Article

Remotely shared CT‐derived presurgical understanding of lung cancer: A randomized trial.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2823, doi. 10.1111/1759-7714.14637

By:

Yoon, Soon Ho;
Na, Kwon Joong;
Kang, Chang Hyun;
Park, In Kyu;
Park, Samina;
Goo, Jin Mo;
Kim, Young Tae

Publication type:

Article

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2792, doi. 10.1111/1759-7714.14627

By:

Falanga, Francesco;
Rinaldi, Pietro;
Primiceri, Cristiano;
Bortolotto, Chandra;
Oneta, Olga;
Agustoni, Francesco;
Morbini, Patrizia;
Saracino, Laura;
Eleftheriou, Dimitrios;
Sottotetti, Federico;
Stella, Giulia Maria

Publication type:

Article

Gut microbiota shed new light on the management of immune‐related adverse events.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2681, doi. 10.1111/1759-7714.14626

By:

Tan, Bei;
Liu, Yun‐xin;
Tang, Hao;
Chen, Dan;
Xu, Yan;
Chen, Min‐jiang;
Li, Yue;
Wang, Meng‐zhao;
Qian, Jia‐ming

Publication type:

Article

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621

By:

Masubuchi, Ken;
Imai, Hisao;
Wasamoto, Satoshi;
Tsuda, Takeshi;
Minemura, Hiroyuki;
Nagai, Yoshiaki;
Yamada, Yutaka;
Kishikawa, Takayuki;
Umeda, Yukihiro;
Shiono, Ayako;
Takechi, Hiroki;
Shiihara, Jun;
Kaira, Kyoichi;
Kanazawa, Kenya;
Taniguchi, Hirokazu;
Kaburagi, Takayuki;
Kagamu, Hiroshi;
Minato, Koichi

Publication type:

Article

What does radiomics do in PD‐L1 blockade therapy of NSCLC patients?

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2669, doi. 10.1111/1759-7714.14620

By:

Cui, Ruichen;
Yang, Zhenyu;
Liu, Lunxu

Publication type:

Article

Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA‐N2 resected non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2767, doi. 10.1111/1759-7714.14617

By:

Jin, Xing;
Chen, Donglai;
Shen, Yumei;
Shu, Jian;
Sang, Yonghua;
Yang, Wentao;
Duan, Shanzhou;
Chen, Yongbing

Publication type:

Article

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2817, doi. 10.1111/1759-7714.14615

By:

Watanabe, Masayuki;
Matsumura, Yuki;
Yamaguchi, Hikaru;
Mine, Hayato;
Takagi, Hironori;
Ozaki, Yuki;
Fukuhara, Mitsuro;
Muto, Satoshi;
Okabe, Naoyuki;
Shio, Yutaka;
Suzuki, Hiroyuki

Publication type:

Article

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2812, doi. 10.1111/1759-7714.14613

By:

Ogata, Ryosuke;
Soda, Hiroshi;
Senju, Hiroaki;
Fujioka, Masaki;
Shimada, Midori;
Yamashita, Koki;
Irifune, Satoshi;
Tagawa, Ryuta;
Dotsu, Yosuke;
Iwasaki, Keisuke;
Taniguchi, Hirokazu;
Takemoto, Shinnosuke;
Fukuda, Yuichi;
Mukae, Hiroshi

Publication type:

Article

Dietary acid load and esophageal cancer risk: A case‐control study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2759, doi. 10.1111/1759-7714.14612

By:

Ronco, Alvaro Luis;
Martínez‐López, Wilner;
Calderón, Juan M.;
Storz, Maximilian Andreas

Publication type:

Article

Short‐term outcomes in patients with lung cancer‐associated acute ischemic stroke.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2751, doi. 10.1111/1759-7714.14611

By:

Wang, Ruixia;
Xu, Peijun;
Zhou, Jun;
Meng, Yuanyuan;
Men, Kun;
Zhang, Jinyuan;
Lu, Wei;
Xue, Juanjuan;
Li, Xin

Publication type:

Article

Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2786, doi. 10.1111/1759-7714.14610

By:

Yang, Dongyang;
Xu, Fei;
Li, Ying;
Lai, Xiaorong;
Xian, Bohong;
Yu, Pengli;
Chen, Rongrong;
Li, Zijun;
Ma, Dong

Publication type:

Article

Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2808, doi. 10.1111/1759-7714.14609

By:

Kim, Yoonjoo;
Park, Dongil;
Choi, Song‐Yi;
Chung, Chaeuk

Publication type:

Article

Retrospective analysis of independent predictors of progression‐free survival in patients with EGFR mutation‐positive advanced non‐small cell lung cancer receiving first‐line osimertinib.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2741, doi. 10.1111/1759-7714.14608

By:

Teranishi, Shuhei;
Sugimoto, Chihiro;
Nagaoka, Satoshi;
Nagayama, Hirokazu;
Segawa, Wataru;
Miyasaka, Atsushi;
Hiro, Shuntaro;
Kajita, Yukihito;
Maeda, Chihiro;
Kobayashi, Nobuaki;
Yamamoto, Masaki;
Kudo, Makoto;
Kaneko, Takeshi

Publication type:

Article

Division of the intersegmental demarcation using the "modified hand‐tearing method" is safe and feasible in thoracoscopic anatomical segmentectomy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2732, doi. 10.1111/1759-7714.14607

By:

Feng, Zhen;
Hu, Benchuang;
Yu, Shuliang;
Guo, Chenran;
Peng, Zhongmin

Publication type:

Article

Lung‐specific exosomes for co‐delivery of CD47 blockade and cisplatin for the treatment of non–small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2723, doi. 10.1111/1759-7714.14606

By:

Cui, Zhilei;
Ruan, Zhengshang;
Zeng, Junxiang;
Sun, Jinyuan;
Ye, Wenjing;
Xu, Weiguo;
Guo, Xuejun;
Zhang, Linlin;
Song, Lin

Publication type:

Article

Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2711, doi. 10.1111/1759-7714.14604

By:

Li, Yujing;
Wang, Yanan;
Zhou, Wensheng;
Chen, Ya;
Lou, Yuqing;
Qian, Fangfei;
Lu, Jun;
Jiang, Haohua;
Xiang, Biao;
Zhang, Yanwei;
Han, Baohui;
Zhang, Wei

Publication type:

Article

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2799, doi. 10.1111/1759-7714.14602

By:

Bai, Rilan;
Jia, Lin;
Gao, Yangyang;
Sun, Xu;
Chen, Naifei;
Lv, Zheng;
Cui, Jiuwei

Publication type:

Article

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2699, doi. 10.1111/1759-7714.14596

By:

Laurent, Adeline;
Marechal, Raphael;
Farinella, Eleonora;
Bouazza, Fikri;
Charaf, Yassine;
Gay, France;
Van Laethem, Jean‐Luc;
Gonsette, Kimberly;
El Nakadi, Issam

Publication type:

Article

Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 19, p. 2692, doi. 10.1111/1759-7714.14531

By:

Buja, Alessandra;
Pasello, Giulia;
Schiavon, Marco;
De Luca, Giuseppe;
Rivera, Michele;
Cozzolino, Claudia;
De Polo, Anna;
Scioni, Manuela;
Bortolami, Alberto;
Baldo, Vincenzo;
Conte, PierFranco

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2022, v. 13, n. 19, p. 2667, doi. 10.1111/1759-7714.14033
Publication type:: Article